Novel Biomaterials for Medical Applications 2017: Investing in Innovative IP Is Vital to Current Competitive Landscape - Research and Markets

DUBLIN--()--The "Novel Biomaterials for Medical Applications" report has been added to Research and Markets' offering.

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the synergies for partnership initiative within the industry, reviewing the roles and strategies of both existing and emerging participants.

Key Questions Answered by this RS:

1. What is the role played by NPD (new product development) and R&D (research and development) initiatives in improving the overall adoption of biomaterials technologies across medical applications?

2. What are the ongoing shifts in the healthcare needs which are largely driving research and development of biomaterials?

3. What are the potential technology-enabled business opportunities that could be explored by existing competitors, and new players entering into the global industry for the biomaterials?

4. Investments in hybrid biomaterials are expected to increase. What are the strategic priorities of existing and new participants in developing the global market?

Key Topics Covered:

1.0 Executive Summary

1.1 Scope of Research

1.2 Research Methodology

1.3 High Scope for Funding Research on Applications of PMMA, PEEK, and PLA

1.4 Application of Biomaterials for Tissue Regeneration is an Actively Explored Area of Research Worldwide

1.5 Success of Clinical Trials is Critical to Market Expansion Efforts of Leading Medical Technology Developers

2.0 Technology Segmentation and Analysis

2.1 Four Major Class of Biomaterials Constitute Over 90% of the Global Market for Medical Applications of Biomaterials

2.2 The Magnitude of Clinical Applications of Biomaterials is Very High for Cardiovascular Applications, Followed by Orthopedic

2.3 Global Technology Development Initiatives Focus on Enhancing Functional Aspects and Durability of Medical Implants

2.4 Commercial Attractiveness and Intensity of IP for Applications of Polymeric Biomaterials is High

2.5 Favorable Economical and Technical Impact of Biomaterials across Various Medical Applications Drive Global R&D Efforts

2.6 Polyethylene, Titanium Alloys, Silicone Rubber are Most Widely Used Biomaterials in Fabrication of Clinically Effective Medical implants

2.7 Growing Demand for Newer Classes of Biomaterials Push Product Development Efforts across the Asia Pacific Region

2.8 3D Printing of Metals and Metal Alloys Enable Fabrication of Implants that Mimic Functions of Cancellous Bone Structures

3.0 Global Technology Development Trends

3.1 Clinical Trials Demonstrating Safety and Efficacy of Biomaterials Drive their Adoption across the Value Chain

3.2 Hybrid Biomaterials that Combine Metals and Polymers Increase the Clinical Value of Medical Implants

3.3 Demonstrating Clinical Value of Implants is Critical to Sustainable Adoption of Newer Classes of Biomaterials

3.4 Metallic and Polymeric Biomaterials Exhibit High Potential for Investments from Venture Capital and Private Equity Firms

3.5 Over 80% of Private Investments is Restricted to Technology Development and Clinical Evaluation of Biomaterials

4.0 Key Recommendations to Industry Stakeholders

4.1 Technologies Available for Licensing are Very High for the Clinical Application of Polymeric & Natural Biomaterials

4.2 Diversification Efforts of Technology Developers Focus on Enhancing Effectiveness and Durability of Medical Implants

4.3 Magnitude of In-house Scientific Research is Very High for Polymeric Biomaterials Despite Low Availability of Research Grants

5.0 Patent Landscape Assessment

5.1 The Ratio of Granted and Applied Patents Strike a Right Balance across Various Classes of Biomaterials Used in Medical Applications

5.2 Spain and Germany are Jurisdictions with Key Patents Focusing on the Synthesis of Biomaterials for Tissue Regeneration Applications

5.3 Cured-oil Hydrogel Biomaterials are Actively Explored as Effective Carriers in the Fabrication of Drug Delivery Systems

5.4 3D Printing Techniques and Materials are Actively Explored by Academic Research Groups for Fabricating Medical Implants

5.5 Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/87x4nc/novel

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials